drug · gene
patient view →axicabtagene ciloleucel
Phase 3updated 2mo agoby $GILD GILEAD SCIENCES, INC.🔗 ChEMBL
Phase 3community read0 votes
Gene drug with a maximum clinical stage of Approval (across all indications), with an approval for follicular lymphoma and diffuse large b-cell lymphoma and 5 investigational indications.
indications
indications
DLBCL
targets
B-lymphocyte antigen CD19
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that